RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Autism - Pipeline Review, H2 2011
Sep 2011 - 79 pages - $500
IntegraGen S.A (ALINT) - Product Pipeline Analysis
Mar 2011 - 20 pages - $750
Epidemiology: Autism Spectrum Disorders - Increasing recognition drives growth of treatable population
Feb 2011 - 42 pages - $5,700
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Autism - Drug Pipeline Analysis and Market Forecasts to 2016
Feb 2010 - 30 pages - $2,000
Autism Speaks, Inc. - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
National Institute of Neurological Disorders and Stroke – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Autism - Pipeline Review, Q1 2011
Feb 2011 - 52 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Assay systems del
Therapeutic target
Central Nervous System del
Neurological del
Autism del
Development phase
Phase II del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us